Screening program in high-risk populations

Ryota Masuzaki; Masao Omata

doi:10.1007/978-1-60327-522-4_4

Screening program in high-risk populations

Ryota Masuzaki, Masao Omata

The University of Tokyo

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

4 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide [1-5]. The majority of patients with HCC have a background of chronic liver disease, especially chronic hepatitis due to hepatitis C virus (HCV) or hepatitis B virus (HBV) infection [6, 7]. Thus, at least some high-risk patients for HCC can be readily defined. Indeed, HCC surveillance is commonly performed as part of the standard clinical examination of patients with chronic viral hepatitis [8].

Original language	English
Title of host publication	Hepatocellular Carcinoma
Subtitle of host publication	Targeted Therapy and Multidisciplinary Care
Publisher	Springer New York
Pages	55-68
Number of pages	14
ISBN (Print)	9781603275217
DOIs	https://doi.org/10.1007/978-1-60327-522-4_4
Publication status	Published - 2011
Externally published	Yes

Keywords

AFP
Screening
Surveillance
Ultrasonography

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-60327-522-4_4

Cite this

@inbook{10cc609c339949e2978a38a6f83b6cc3,

title = "Screening program in high-risk populations",

abstract = "Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide [1-5]. The majority of patients with HCC have a background of chronic liver disease, especially chronic hepatitis due to hepatitis C virus (HCV) or hepatitis B virus (HBV) infection [6, 7]. Thus, at least some high-risk patients for HCC can be readily defined. Indeed, HCC surveillance is commonly performed as part of the standard clinical examination of patients with chronic viral hepatitis [8].",

keywords = "AFP, Screening, Surveillance, Ultrasonography",

author = "Ryota Masuzaki and Masao Omata",

year = "2011",

doi = "10.1007/978-1-60327-522-4_4",

language = "English",

isbn = "9781603275217",

pages = "55--68",

booktitle = "Hepatocellular Carcinoma",

publisher = "Springer New York",

}

TY - CHAP

T1 - Screening program in high-risk populations

AU - Masuzaki, Ryota

AU - Omata, Masao

PY - 2011

Y1 - 2011

N2 - Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide [1-5]. The majority of patients with HCC have a background of chronic liver disease, especially chronic hepatitis due to hepatitis C virus (HCV) or hepatitis B virus (HBV) infection [6, 7]. Thus, at least some high-risk patients for HCC can be readily defined. Indeed, HCC surveillance is commonly performed as part of the standard clinical examination of patients with chronic viral hepatitis [8].

AB - Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide [1-5]. The majority of patients with HCC have a background of chronic liver disease, especially chronic hepatitis due to hepatitis C virus (HCV) or hepatitis B virus (HBV) infection [6, 7]. Thus, at least some high-risk patients for HCC can be readily defined. Indeed, HCC surveillance is commonly performed as part of the standard clinical examination of patients with chronic viral hepatitis [8].

KW - AFP

KW - Screening

KW - Surveillance

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=84889961748&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-522-4_4

DO - 10.1007/978-1-60327-522-4_4

M3 - Chapter

AN - SCOPUS:84889961748

SN - 9781603275217

SP - 55

EP - 68

BT - Hepatocellular Carcinoma

PB - Springer New York

ER -

Screening program in high-risk populations

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this